ANPEP and cancer: Nicotinic acetylcholine receptors can be used for targeting neuronal cells, while αvβ3 integrin and CD13/APN receptors are well-known examples of receptors overexpressed in the brain tumor microenvironment, allowing the development of novel therapies that specifically target the cancer cells in the brain tissue [58,59].